| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 18 |
| 1 | ASPIRIN 325 MG | 18 |
| 2 | ASPIRIN 81 MG | 18 |
| 3 | PANTOPRAZOLE SODIUM | 18 |
| 4 | FUROSEMIDE | 17 |
| 5 | ATORVASTATIN CALCIUM | 13 |
| 6 | LISINOPRIL | 13 |
| 7 | LEVOTHYROXINE SODIUM | 12 |
| 8 | FLUOROURACIL | 11 |
| 9 | FLUOROURACIL CREAM, 0.5% | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACETAMINOPHEN, IBUPROFEN | 1 | 0.0027 |
| 1 | AMIFOSTINE | 2 | 0.0025 |
| 2 | MEXILETINE HYDROCHLORIDE | 1 | 0.0024 |
| 3 | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | 1 | 0.0022 |
| 4 | EPTIFIBATIDE | 1 | 0.0013 |
| 5 | IXABEPILONE | 1 | 0.0010 |
| 6 | PROBENECID | 1 | 0.0008 |
| 7 | METHYLPHENIDATE HCL | 1 | 0.0008 |
| 8 | NATEGLINIDE | 1 | 0.0007 |
| 9 | GEMTUZUMAB OZOGAMICIN | 2 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 35 |
| 1 | Corticosteroid [EPC] | 29 |
| 2 | Platinum-based Drug [EPC] | 21 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 20 |
| 4 | Benzodiazepine [EPC] | 19 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 19 |
| 6 | Loop Diuretic [EPC] | 17 |
| 7 | Proton Pump Inhibitor [EPC] | 16 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 13 |
| 9 | Alkylating Drug [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD33-directed Immunoconjugate [EPC] | 2 | 0.0005 |
| 1 | Photoenhancer [EPC] | 2 | 0.0005 |
| 2 | Cannabinoid [EPC] | 2 | 0.0002 |
| 3 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 2 | 0.0002 |
| 4 | Polyene Antifungal [EPC] | 5 | 0.0001 |
| 5 | Glinide [EPC] | 1 | 0.0001 |
| 6 | Cardiac Glycoside [EPC] | 8 | 0.0001 |
| 7 | Epidermal Growth Factor Receptor Antagonist [EPC] | 5 | 0.0001 |
| 8 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 9 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |